Home

Biosidus S.A.U. sell "Agalzyme"

Basic Information

1.2K
82
16
3.7(49)

Subcategory & Sub-subcategory

Trade Type

Sell

Product Name

Agalzyme

Details

Manufacturer(s)

Specifications

  • Purity: Demonstrated therapeutic bioequivalence, efficacy and safety comparable to the reference agalsidase beta product across preclinical and Phase I/III clinical studies.
  • Assay: Manufactured under ICH guidelines as a recombinant enzyme (agalsidase beta) for long-term enzyme replacement therapy in Fabry disease.
  • CAS Number: Not applicable — a recombinant protein biologic (agalsidase beta), identified by INN rather than a CAS Registry Number.

Documents

GMP
ISO
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Biosidus S.A.U. sell "Agalzyme" | PharmaCountry